The Dynamic Lung Microbiome in Health and Disease

Overview

Journal Nat Rev Microbiol

Specialties Infectious Diseases
Microbiology

Date 2022 Nov 17

PMID 36385637

Authors

Jake G Natalini

Shivani Singh

Leopoldo N Segal

Affiliations

Soon will be listed here.

Abstract

New methods and technologies within the field of lung biology are beginning to shed new light into the microbial world of the respiratory tract. Long considered to be a sterile environment, it is now clear that the human lungs are frequently exposed to live microbes and their by-products. The nature of the lung microbiome is quite distinct from other microbial communities inhabiting our bodies such as those in the gut. Notably, the microbiome of the lung exhibits a low biomass and is dominated by dynamic fluxes of microbial immigration and clearance, resulting in a bacterial burden and microbiome composition that is fluid in nature rather than fixed. As our understanding of the microbial ecology of the lung improves, it is becoming increasingly apparent that certain disease states can disrupt the microbial-host interface and ultimately affect disease pathogenesis. In this Review, we provide an overview of lower airway microbial dynamics in health and disease and discuss future work that is required to uncover novel therapeutic targets to improve lung health.

Citing Articles

Burn inhalation injury and intubation with dexamethasone-eluting endotracheal tubes modulate local microbiome and alter airway inflammation.

Gonzales G, Malka R, Bizios R, Dion G, Guda T Front Bioeng Biotechnol. 2025; 13:1524013.

PMID: 40078791 PMC: 11897493. DOI: 10.3389/fbioe.2025.1524013.

mNGS-based dynamic pathogen monitoring for accurate diagnosis and treatment of severe pneumonia caused by fungal infections.

Li Z, Wu C, Tang L, Liang Y, A R, Huang D Biosaf Health. 2025; 5(3):138-143.

PMID: 40078515 PMC: 11895042. DOI: 10.1016/j.bsheal.2023.04.004.

Upper and lower airway microbiota across infancy and childhood.

Hernandez-Leyva A, Rosen A, Tomera C, Lin E, Akaho E, Blatz A Pediatr Res. 2025; .

PMID: 40075175 DOI: 10.1038/s41390-025-03942-0.

The Microbiome in Asthma Heterogeneity: The Role of Multi-Omic Investigations.

Huang Y Immunol Rev. 2025; 330(1):e70015.

PMID: 40072031 PMC: 11899502. DOI: 10.1111/imr.70015.

A mass spectrometry-based strategy for investigating volatile molecular interactions in microbial consortia: unveiling a -specific induction of an antifungal compound.

Azzollini A, Sgorbini B, Lecoultre N, Bicchi C, Wolfender J, Rubiolo P Front Microbiol. 2025; 15:1417919.

PMID: 40070966 PMC: 11895703. DOI: 10.3389/fmicb.2024.1417919.

References

Lloyd-Price J, Abu-Ali G, Huttenhower C . The healthy human microbiome. Genome Med. 2016; 8(1):51. PMC: 4848870. DOI: 10.1186/s13073-016-0307-y. View

de Steenhuijsen Piters W, Binkowska J, Bogaert D . Early Life Microbiota and Respiratory Tract Infections. Cell Host Microbe. 2020; 28(2):223-232. DOI: 10.1016/j.chom.2020.07.004. View

Sulaiman I, Wu B, Li Y, Tsay J, Sauthoff M, Scott A . Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism. Eur Respir J. 2021; 58(1). PMC: 8643072. DOI: 10.1183/13993003.03434-2020. View

Wu B, Sulaiman I, Tsay J, Perez L, Franca B, Li Y . Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to . Am J Respir Crit Care Med. 2020; 203(9):1099-1111. PMC: 8314894. DOI: 10.1164/rccm.202005-1596OC. View

Thorsen J, Rasmussen M, Waage J, Mortensen M, Brejnrod A, Bonnelykke K . Infant airway microbiota and topical immune perturbations in the origins of childhood asthma. Nat Commun. 2019; 10(1):5001. PMC: 6825176. DOI: 10.1038/s41467-019-12989-7. View

Dickson R, Erb-Downward J, Freeman C, McCloskey L, Beck J, Huffnagle G . Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography. Ann Am Thorac Soc. 2015; 12(6):821-30. PMC: 4590020. DOI: 10.1513/AnnalsATS.201501-029OC. View

Charlson E, Bittinger K, Haas A, Fitzgerald A, Frank I, Yadav A . Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011; 184(8):957-63. PMC: 3208663. DOI: 10.1164/rccm.201104-0655OC. View

Dickson R, Erb-Downward J, Freeman C, McCloskey L, Falkowski N, Huffnagle G . Bacterial Topography of the Healthy Human Lower Respiratory Tract. mBio. 2017; 8(1). PMC: 5312084. DOI: 10.1128/mBio.02287-16. View

10.

Segal L, Clemente J, Tsay J, Koralov S, Keller B, Wu B . Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 2016; 1:16031. PMC: 5010013. DOI: 10.1038/nmicrobiol.2016.31. View

11.

Huang Y, Nariya S, Harris J, Lynch S, Choy D, Arron J . The airway microbiome in patients with severe asthma: Associations with disease features and severity. J Allergy Clin Immunol. 2015; 136(4):874-84. PMC: 4600429. DOI: 10.1016/j.jaci.2015.05.044. View

12.

ODwyer D, Zhou X, Wilke C, Xia M, Falkowski N, Norman K . Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation. Am J Respir Crit Care Med. 2018; 198(10):1312-1321. PMC: 6290939. DOI: 10.1164/rccm.201712-2456OC. View

13.

Segal L, Clemente J, Li Y, Ruan C, Cao J, Danckers M . Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients. Cell Host Microbe. 2017; 21(4):530-537.e4. PMC: 5465639. DOI: 10.1016/j.chom.2017.03.003. View

14.

Erb-Downward J, Thompson D, Han M, Freeman C, McCloskey L, Schmidt L . Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011; 6(2):e16384. PMC: 3043049. DOI: 10.1371/journal.pone.0016384. View

15.

Dickson R, Erb-Downward J, Huffnagle G . The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013; 7(3):245-57. PMC: 4007100. DOI: 10.1586/ers.13.24. View

16.

Garcia-Nunez M, Millares L, Pomares X, Ferrari R, Perez-Brocal V, Gallego M . Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J Clin Microbiol. 2014; 52(12):4217-23. PMC: 4313290. DOI: 10.1128/JCM.01967-14. View

17.

Tsay J, Wu B, Badri M, Clemente J, Shen N, Meyn P . Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med. 2018; 198(9):1188-1198. PMC: 6221574. DOI: 10.1164/rccm.201710-2118OC. View

18.

Gustafson A, Soldi R, Anderlind C, Scholand M, Qian J, Zhang X . Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med. 2010; 2(26):26ra25. PMC: 3694402. DOI: 10.1126/scitranslmed.3000251. View

19.

Sethi S, Maloney J, Grove L, Wrona C, Berenson C . Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173(9):991-8. PMC: 2662918. DOI: 10.1164/rccm.200509-1525OC. View

20.

Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A . Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999; 14(5):1015-22. DOI: 10.1183/09031936.99.14510159. View

21.

Bresser P, Out T, van Alphen L, Jansen H, Lutter R . Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):947-52. DOI: 10.1164/ajrccm.162.3.9908103. View